Proton Pump Inhibitors (PPI): Class Labeling Change

Possible increased risk of fractures of the hip, wrist, and spine.

Related Posts:

1. Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures
2. GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer
3. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
4. Zocor (simvastatin): increased risk of muscle injury with high doses
5. Wrist Rattles and Baby Booties Recalled by Midwest-CBK Due to Choking Hazard